Skip to main content
. 2015 Aug 1;9(8):NC01–NC04. doi: 10.7860/JCDR/2015/13277.6288

[Table/Fig-3]:

Clinical characteristics of patients with anisoastigmatism

S. No. Age/Sex Amblyopic Eye Fellow Eye
BCVA Pre therapy Log Mar Units Prescription BCVA Post therapy BCVA Pre therapy Log Mar Units Prescription BCVA Post therapy
1. 23year/M 20/63 0.5 -2.25DCx90° 20/20 20/20 00 -0.75DCx90° 20/20
2. 14year/M 20/63 0.5 -1.50DCx70° 20/20 20/20 00 - 20/20
3. 28year/F 20/200 1.0 -3.25DCx180° 20/40 20/20 00 -0.5DCx160° 20/20
4. 15year/M 20/125 0.8 -3DCx180° 20/40 20/25 0.1 -1DCx180° 20/20
5. 13year/M 20/80 0.6 -2.5DCx80° 20/20 20/20 00 -1DCx90° 20/20
6. 12year/M 20/63 0.5 +2DCx90° 20/25 20/20 00 +0.50DCx90° 20/20
7. 12year/M 20/200 1.0 -3DCx80° 20/40 20/25 0.1 -1.50DCx80° 20/20
8. 12year/M 20/80 0.6 -1DS/ -2DCx90° 20/20 20/20 00 -0.50DCx60° 20/20
9. 12year/F 20/80 0.6 -3.50DCx110° 20/25 20/40 0.3 -1.50DCx180° 20/20
10. 14year/F 20/80 0.6 +2.50DCx12° 20/20 20/20 00 -0.50DS 20/20
11. 17year/F 20/125 0.8 +2DCx70° 20/20 20/20 00 - 20/20
12. 22year/F 20/200 1.0 -2.50DCx90° 20/20 20/20 00 - 20/20
13. 15year/F 20/125 0.8 -0.50DS/ -2DCx90° 20/20 20/20 00 -1.00DS 20/20
14. 18year/F 20/125 0.8 -2.75DS/
-1.75DCx90°
20/40 20/20 00 -0.75DS/
-0.25DCx90°
20/20
15. 15year/F 20/125 0.8 -3DCx120° 20/25 20/20 00 -0.75DCx60° 20/20
16. 15year/M 20/400 02 -1.00DS/
-4.25DCx180°
20/40 20/40 0.3 -1.50DCx180° 20/20
17. 18year/M 20/200 1.0 -2.25DCx90° 20/25 20/20 00 +0.50DS/
-0.50DCx90°
20/20
18. 18year/F 20/200 1.0 -0.25DS/
-2.50DCx60°
20/25 20/25 0.1 -1DCx60° 20/20
19. 19year/M** 20/200 1.0 -0.50DS/
-2.75DCx90°
20/50 20/20 00 -1.75DS 20/20
20. 15year/M 20/200 1.0 -2.75DCx80° 20/20 20/20 00 - 20/20

**Did not fulfill criteria of successful treatment